A: Triamcinolone acetonide for Vitiligo

Phase 2

Waitlist Available

Led By Harvey Lui, MD, FRCPC

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Summary

This trial is studying the effectiveness of corticosteroid injections to treat vitiligo, a skin condition causing white patches and marks. The effects & safety of the injections are being compared over 4-6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: A: Triamcinolone acetonideActive Control1 Intervention

Injections will be given within one half of a single vitiligo patch. The concentration of triamcinolone acetonide (TA) that will be used initially is 2.5 mg/ml. Dilution will be done using a bacteriostatic normal saline. Each half will receive injections with either TA 2.5 mg/ml or normal saline as a control. Only one investigator will know the intervention each half has received. If the patient did not show any evidence of repigmentation during the 3rd visit (i.e. after two injection sessions with TA 2.5 mg/ml) , the concentration of TA will be increased to 5 mg/ml. A total of 4 injections will be given over 4 visits. The treatment will be repeated every 3 to 5 weeks for a total of 4 treatment sessions.

Group II: B: Normal salinePlacebo Group1 Intervention

Bacteriostatic normal saline will injected into one half of the vitiligo patch.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor

1,451 Previous Clinical Trials

2,483,172 Total Patients Enrolled

4 Trials studying Vitiligo

107 Patients Enrolled for Vitiligo

Harvey Lui, MD, FRCPCPrincipal InvestigatorUniversity of British Columbia

3 Previous Clinical Trials

62 Total Patients Enrolled

3 Trials studying Vitiligo

62 Patients Enrolled for Vitiligo

~1 spots leftby Sep 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.